SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
27.07
-0.58 (-2.10%)
Sep 25, 2026, 4:00 PM EDT - Market closed
SpyGlass Pharma Employees
SpyGlass Pharma had 76 employees as of June 30, 2026.
Employees
76
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$737,539
Market Cap
905.44M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 76 | - | - |
| Mar 31, 2026 | 68 | - | - |
| Dec 31, 2025 | 65 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Kura Oncology | 260 |
| Alumis | 239 |
| Rigel Pharmaceuticals | 174 |
| Sana Biotechnology | 142 |
| Cullinan Therapeutics | 109 |
| Cybin | 100 |
| Apnimed | 81 |
SGP News
- 13 days ago - SpyGlass Pharma Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 17 days ago - SpyGlass Pharma Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 25 days ago - SpyGlass Pharma to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - SpyGlass Pharma initiated with an Outperform at Raymond James - TheFly
- 7 weeks ago - SpyGlass Pharma reports Q2 EPS (59c), consensus (55c) - TheFly
- 7 weeks ago - SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 7 weeks ago - SpyGlass Pharma Earnings release: Q2 2026 - Filings
- 7 weeks ago - SpyGlass Pharma Quarterly report: Q2 2026 - Filings